• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 3. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 4. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 5. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles 4,5-disubstituted oxazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Oxazoles 4,5-disubstituted oxazoles

Ethyl 5-Ethyl-1,3-Oxazole-4-Carboxylate (CAS No. 32968-45-9): A Comprehensive Overview

Ethyl 5-ethyl-1,3-oxazole-4-carboxylate (CAS No. 32968-45-9) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound belongs to the class of oxazoles, which are known for their diverse biological activities and potential applications in drug discovery. The unique structure of ethyl 5-ethyl-1,3-oxazole-4-carboxylate makes it a valuable intermediate in the synthesis of various bioactive molecules, including anti-inflammatory agents, antimicrobial compounds, and anticancer drugs.

The chemical structure of ethyl 5-ethyl-1,3-oxazole-4-carboxylate consists of an oxazole ring with an ethyl substituent at the 5-position and an ethyl ester group at the 4-position. This configuration imparts specific physical and chemical properties that are crucial for its utility in synthetic pathways. The compound is typically synthesized through a multi-step process involving condensation reactions and esterification steps. Recent advancements in synthetic methodologies have led to more efficient and environmentally friendly routes for the production of this compound, enhancing its accessibility for large-scale applications.

In the realm of medicinal chemistry, ethyl 5-ethyl-1,3-oxazole-4-carboxylate has been explored for its potential therapeutic properties. Studies have shown that derivatives of this compound exhibit significant anti-inflammatory activity, making them promising candidates for the treatment of inflammatory diseases such as rheumatoid arthritis and Crohn's disease. The anti-inflammatory effects are attributed to the ability of these derivatives to modulate key signaling pathways involved in inflammation, such as the NF-κB pathway.

Beyond its anti-inflammatory properties, ethyl 5-ethyl-1,3-oxazole-4-carboxylate has also been investigated for its antimicrobial activity. Research has demonstrated that certain derivatives of this compound possess broad-spectrum antimicrobial properties against both Gram-positive and Gram-negative bacteria. This makes it a potential lead compound for the development of new antibiotics, which is particularly important given the growing concern over antibiotic resistance.

In addition to its biological activities, ethyl 5-ethyl-1,3-oxazole-4-carboxylate has been used as a building block in the synthesis of anticancer drugs. The oxazole ring is known to be a privileged scaffold in cancer therapy due to its ability to interact with various biological targets involved in cancer progression. For instance, derivatives of this compound have been shown to inhibit key enzymes such as topoisomerases and kinases, which are essential for DNA replication and cell division in cancer cells.

The pharmacokinetic properties of ethyl 5-ethyl-1,3-oxazole-4-carboxylate and its derivatives are also an important area of research. Studies have focused on optimizing the solubility, stability, and bioavailability of these compounds to enhance their therapeutic efficacy. Techniques such as prodrug design and nanoparticle formulation have been employed to improve these properties, making it possible to deliver these compounds more effectively to target tissues.

In conclusion, ethyl 5-ethyl-1,3-oxazole-4-carboxylate (CAS No. 32968-45-9) is a multifaceted compound with a wide range of applications in medicinal chemistry and pharmaceutical research. Its unique structure and diverse biological activities make it a valuable intermediate in the synthesis of bioactive molecules with potential therapeutic benefits. Ongoing research continues to uncover new possibilities for this compound, further solidifying its importance in the field.

• 827028-62-6(4-Oxazolecarboxylic acid, 5-cyclohexyl-, methyl ester)
• 41172-57-0(methyl 5-methyl-1,3-oxazole-4-carboxylate)
• 89007-02-3(4-Oxazolecarboxylic acid, 5-pentyl-, methyl ester)
• 32968-44-8(Ethyl 5-Methyl-4-oxazolecarboxylate)
• 166950-00-1(Methyl 5-(2-aminoethyl)oxazole-4-carboxylate)
• 89006-96-2(5-(propan-2-yl)-1,3-oxazole-4-carboxylic acid)
• 920023-42-3(4-Oxazolecarboxylic acid, 5-cyclopropyl-2-methyl-, ethyl ester)
• 23000-15-9(ethyl 2,5-dimethyl-1,3-oxazole-4-carboxylate)
• 72030-85-4(methyl 5-(propan-2-yl)-1,3-oxazole-4-carboxylate)
• 898227-93-5(5-ethyl-1,3-oxazole-4-carboxylic acid)